CLC bio Acquires the Drug Discovery-software Company Molegro
Published: Monday, September 03, 2012 Last Updated: Monday, September 03, 2012
The acquisition of Molegro supports CLC bio's strategy of continuously expanding their bioinformatics offerings beyond Next Generation Sequencing, as well as in bioinformatics areas of value to their customer base.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.